Testing effectiveness (Phase 2)Study completedNCT02052739
What this trial is testing
Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
Who this might be right for
Super-refractory Status Epilepticus
Supernus Pharmaceuticals, Inc. 25